Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00037193 · ClinicalTrials.gov registry record

Acute Regulation of Parathyroid Hormone by Dietary Phosphate

A clinical trial, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status

NCT00037193 is a clinical trial that has completed, run by National Center for Research Resources (NCRR).

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00037193 has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status

Study Summary

Patients with end stage renal disease often have secondary hyperparathyroidism due to high phosphorus and low calcium levels in the blood. Preliminary animal studies and our initial human study indicate that the parathyroid hormone levels may change quickly based on the ingestion of phosphorus, prior to any change in the blood levels of calcium or phosphorus. This follow-up study will attempt to determine if the effect is independent of an increase in the blood glucose level. If so, this would suggest an as yet unidentified gastrointestinal receptor that mediates parathyroid hormone levels. This may affect the timing of administration and the type of phosphate binder used in treating patients with secondary hyperparathyroidism. The knowledge that parathyroid hormone levels can change acutely may also affect the recommended timing of blood samples

Trial Details

FieldValue

What the Registry Record Tells You About NCT00037193

The ClinicalTrials.gov registry entry for NCT00037193 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00037193 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00037193 about?

NCT00037193 is a clinical study titled "Acute Regulation of Parathyroid Hormone by Dietary Phosphate". Patients with end stage renal disease often have secondary hyperparathyroidism due to high phosphorus and low calcium levels in the blood. Preliminary animal studies and our initial human study indicate that the parathyroid hormone levels may change quickly based on the ingestion of phosphorus, prio...

What is the current status of trial NCT00037193?

This trial is currently completed.

Who is sponsoring clinical trial NCT00037193?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.